scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1034498928 |
P356 | DOI | 10.1186/S13075-015-0759-2 |
P932 | PMC publication ID | 4556214 |
P698 | PubMed publication ID | 26330334 |
P5875 | ResearchGate publication ID | 281411305 |
P50 | author | Fernando Queiroz Cunha | Q38330464 |
Bernhard Ryffel | Q40398470 | ||
Thiago Mattar Cunha | Q42317688 | ||
Raphael S Peres | Q50859903 | ||
Larissa G Pinto | Q79379068 | ||
Rafael Freitas Oliveira Franca | Q92074510 | ||
Jhimmy Talbot | Q114434537 | ||
Florencio Figueiredo | Q114434559 | ||
P2093 | author name string | Sérgio H Ferreira | |
José Carlos F Aves-Filho | |||
P2860 | cites work | Interleukin (IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R | Q22254431 |
Human interleukin-10-related T cell-derived inducible factor: molecular cloning and functional characterization as an hepatocyte-stimulating factor | Q24290133 | ||
Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A | Q24597173 | ||
IL-22 increases the innate immunity of tissues | Q28276850 | ||
Cytokines in the pathogenesis of rheumatoid arthritis | Q28303865 | ||
The pathogenesis of rheumatoid arthritis | Q29614957 | ||
Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis | Q29620506 | ||
Biology of interleukin-22. | Q30385283 | ||
A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. | Q33819799 | ||
Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta ) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes | Q33921809 | ||
Endogenous IL-22 plays a dual role in arthritis: regulation of established arthritis via IFN-γ responses | Q35133818 | ||
An update on the cytokine network in rheumatoid arthritis | Q35753674 | ||
Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis | Q36371110 | ||
IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation | Q36383605 | ||
IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice | Q36497523 | ||
Protective effect of an extract from Ascaris suum in experimental arthritis models | Q36710601 | ||
Interleukin-22 reduces the severity of collagen-induced arthritis in association with increased levels of interleukin-10. | Q36745327 | ||
Nociceptors are interleukin-1beta sensors | Q37213078 | ||
Evidence that cytokines play a role in rheumatoid arthritis | Q37316594 | ||
IL-22: a critical mediator in mucosal host defense | Q37393834 | ||
Interleukin-22: A cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection | Q37792615 | ||
Regulation and functions of the IL-10 family of cytokines in inflammation and disease | Q37821924 | ||
Recent advances in IL-22 biology. | Q37851777 | ||
Emerging cell and cytokine targets in rheumatoid arthritis | Q38161794 | ||
Antinociceptive effects of tumor necrosis factor alpha neutralization in a rat model of antigen-induced arthritis: evidence of a neuronal target | Q39316366 | ||
Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice | Q39889485 | ||
Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis | Q40587405 | ||
Interleukin-23 is critical for full-blown expression of a non-autoimmune destructive arthritis and regulates interleukin-17A and RORgammat in gammadelta T cells | Q41201554 | ||
ES-62 protects against collagen-induced arthritis by resetting interleukin-22 toward resolution of inflammation in the joints | Q41845753 | ||
Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue | Q41980359 | ||
Regulation of synovial cell proliferation and prostaglandin E2 production by combined action of cytokines. | Q42127670 | ||
IL-17 mediates articular hypernociception in antigen-induced arthritis in mice | Q43227714 | ||
IL-22+ CD4+ T cells in patients with rheumatoid arthritis | Q46431837 | ||
Role of cytokines in mediating mechanical hypernociception in a model of delayed-type hypersensitivity in mice | Q46677501 | ||
IL-17/Th17 mediated synovial inflammation is IL-22 independent | Q46766299 | ||
Crucial role of neutrophils in the development of mechanical inflammatory hypernociception | Q46802148 | ||
Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen-induced arthritis: influence on T helper cell activation | Q47981660 | ||
Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. | Q50485305 | ||
IL-22/IL-22R1 axis and S100A8/A9 alarmins in human osteoarthritic and rheumatoid arthritis synovial fibroblasts. | Q52643628 | ||
Antigen-induced arthritis in mice. I. Induction of arthritis in various strains of mice. | Q54598631 | ||
NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B4 in a murine model of gout | Q56797722 | ||
Dual Role of IL-22 in Allergic Airway Inflammation and its Cross-talk with IL-17A | Q57194260 | ||
CXCR2‐specific chemokines mediate leukotriene B4–dependent recruitment of neutrophils to inflamed joints in mice with antigen‐induced arthritis | Q57232012 | ||
Interleukin-6 modulates production of T lymphocyte–derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis | Q57265520 | ||
Increased expression of interleukin-22 by synovial Th17 cells during late stages of murine experimental arthritis is controlled by interleukin-1 and enhances bone degradation | Q58998716 | ||
Interleukin-1-Induced Prostaglandin E2 Biosynthesis in Human Synovial Cells Involves the Activation of Cytosolic Phospholipase A2 and Cyclooxygenase-2 | Q60321344 | ||
Inflammatory Role of ASC in Antigen-Induced Arthritis Is Independent of Caspase-1, NALP-3, and IPAF | Q63214879 | ||
Adoptive transfer of susceptibility to antigen-induced arthritis into severe combined immunodeficient (SCID) mice: role of CD4+ and CD8+ T cells | Q71526472 | ||
Fucoidin, but not yeast polyphosphomannan PPME, inhibits leukocyte rolling in venules of the rat mesentery | Q72067028 | ||
Expression of interleukin-1 beta in rat dorsal root ganglia | Q74348655 | ||
Sensitization of unmyelinated sensory fibers of the joint nerve to mechanical stimuli by interleukin-6 in the rat: an inflammatory mechanism of joint pain | Q79461290 | ||
Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts | Q82240437 | ||
IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis | Q83163682 | ||
GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis | Q83398970 | ||
Elevated Th22 cells correlated with Th17 cells in patients with rheumatoid arthritis | Q84071185 | ||
Increased serum interleukin 22 in patients with rheumatoid arthritis and correlation with disease activity | Q84141763 | ||
Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritis | Q84142069 | ||
Interleukin-17 sensitizes joint nociceptors to mechanical stimuli and contributes to arthritic pain through neuronal interleukin-17 receptors in rodents | Q85564347 | ||
P304 | page(s) | 235 | |
P577 | publication date | 2015-09-02 | |
P1433 | published in | Arthritis Research and Therapy | Q15757229 |
P1476 | title | Joint production of IL-22 participates in the initial phase of antigen-induced arthritis through IL-1β production | |
P478 | volume | 17 |
Q90640413 | Clinical-like cryotherapy improves footprint patterns and reduces synovial inflammation in a rat model of post-traumatic knee osteoarthritis |
Q50426470 | Divergent roles of immune cells and their mediators in pain |
Q42347098 | IL‑22 expression is increased variedly in the initial phase, onset and chronic phase of a pristane‑induced arthritis rat model. |
Q64095614 | Knee osteoarthritis induces atrophy and neuromuscular junction remodeling in the quadriceps and tibialis anterior muscles of rats |
Q42317643 | Lapachol, a compound targeting pyrimidine metabolism, ameliorates experimental autoimmune arthritis |
Q60920920 | Neutrophil Function in an Inflammatory Milieu of Rheumatoid Arthritis |
Q89475987 | Thirty days after anterior cruciate ligament transection is sufficient to induce signs of knee osteoarthritis in rats: pain, functional impairment, and synovial inflammation |
Search more.